Related references
Note: Only part of the references are listed.HBM Mice Have Altered Bone Matrix Composition and Improved Material Toughness
Ryan D. Ross et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Igor Fijalkowski et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Monica Florio et al.
NATURE COMMUNICATIONS (2016)
LRP4 in neuromuscular junction and bone development and diseases
Chengyong Shen et al.
BONE (2015)
The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5
Timur A. Yorgan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
Lei Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia
Duygu Selcen et al.
JAMA NEUROLOGY (2015)
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner
Bisei Ohkawara et al.
HUMAN MOLECULAR GENETICS (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Dickkopf 1 Levels in Sclerostin Deficiency
A. H. van Lierop et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner
Nicole M. Collette et al.
DEVELOPMENTAL BIOLOGY (2013)
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
Joachim Albers et al.
JOURNAL OF CELL BIOLOGY (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases
Eveline Boudin et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lrp5 functions in bone to regulate bone mass
Yajun Cui et al.
NATURE MEDICINE (2011)
LRP4 Mutations Alter Wnt/β-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz Syndrome
Yun Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Sclerostin: Current Knowledge and Future Perspectives
M. J. C. Moester et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Genetics of osteoporosis: accelerating pace in gene identification and validation
Wen-Feng Li et al.
HUMAN GENETICS (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Lrp4 Regulates Initiation of Ureteric Budding and Is Crucial for Kidney Formation - A Mouse Model for Cenani-Lenz Syndrome
Courtney M. Karner et al.
PLOS ONE (2010)
Collaborative Meta-analysis: Associations of 150 Candidate Genes With Osteoporosis and Osteoporotic Fracture
J. Brent Richards et al.
ANNALS OF INTERNAL MEDICINE (2009)
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies
Fernando Rivadeneira et al.
NATURE GENETICS (2009)
Impaired gastric acidification negatively affects calcium homeostasis and bone mass
Thorsten Schinke et al.
NATURE MEDICINE (2009)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development
Atsushi Ohazama et al.
PLOS ONE (2008)
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
Rutger L. van Bezooijen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction
Scott D. Weatherbee et al.
DEVELOPMENT (2006)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity
N Kusu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High bone mass in mice expressing a mutant LRP5 gene
P Babij et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
AO Hoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators
W Balemans et al.
DEVELOPMENTAL BIOLOGY (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
